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Abstract
Classical dendritic cells (cDC) are specialized antigen-presenting cells mediating immunity and tolerance. cDC cell-
lineage decisions are largely controlled by transcriptional factor regulatory cascades. Using an in vivo cell-specific
targeting of Runx3 at various stages of DC lineage development we show that Runx3 is required for cell-identity,
homeostasis and function of splenic Esamhi DC. Ablation of Runx3 in DC progenitors led to a substantial decrease in
splenic CD4+/CD11b+ DC. Combined chromatin immunoprecipitation sequencing and gene expression analysis of
purified DC-subsets revealed that Runx3 is a key gene expression regulator that facilitates specification and
homeostasis of CD11b+Esamhi DC. Mechanistically, loss of Runx3 alters Esamhi DC gene expression to a signature
characteristic of WT Esamlow DC. This transcriptional reprogramming caused a cellular change that diminished
phagocytosis and hampered Runx3-/- Esamhi DC capacity to prime CD4+ T cells, attesting to the significant role of
Runx3 in specifying Esamhi DC identity and function.
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Introduction
Classical dendritic cells (cDC) are a sparsely distributed,
migratory group of bone-marrow- (BM) derived immune cells
specialized in antigen uptake and presentation [1,2] and as
such important mediators of immunity and tolerance [3,4]. cDC
are divided into two main groups: migratory DC (mDC) and
stationary DC (sDC). mDC are scattered in most body organs
including lung, gut and skin and act as sentinels by sampling
environmental pathogens. Upon activation, mDC migrate to
secondary lymphoid organs and present processed antigens to
T cells. sDC, on the other hand, sample and process antigens
directly in the lymphoid organs. These sDC are heterogeneous
with respect to their cell-surface markers and function and have
based on surface molecules been divided into three major
types: XCR1+ CD8α+/CD4-/CD11b-, CD4+/CD11b+/CD8α - and
CD4−/CD8α− CD11b+ [5]. In addition, splenic CD8α + and CD4+
subsets differ in MHCI and MHCII processing pathways,
reflected in their ability to preferentially induce CD4 or CD8 T
cell responses [6].
Despite their phenotypic and functional heterogeneity all
splenic cDC are derived from a common DC precursor (CDP)
[7]. BM CDP give rise to plasmacytoid DC (pDC) and
circulating pre-DC that seed the peripheral tissues [7]. The
current classification defines two distinct subclasses of splenic
CD11b+ cDC, as CD11b+Esamhi and CD11b+Esamlow cells [8].
Gene expression profiling and functional analysis of these two
CD11b+ cDC subclasses have suggested that CD11b+Esamlow
DC are related to monocytes rather than to cDC and therefore
could have derived from the monocyte/dendritic cell precursor
(MDP) without involving a CDP intermediate [8]. Generation of
CD11b+Esamhi/CD11b+Esamlow DC is controlled by the Notch2
pathway, so that loss of Notch2 signaling selectively affects the
development of CD11b+Esamhi DC [8].
Several transcription factors (TF) affect DC lineage
development and function. Mice lacking the TF Id2, Irf8 or
Batf3 are deficient in CD8+ DC [9-11] and loss of Irf4 TF affects
CD4+ DC development [12]. On the other hand, loss of the
cDC-specific TF zDC (Zbtb46) [13,14] did not impair DC
development, but was associated with increased activation of
naive cDC [15].
Runx3 TF is highly expressed in mature BM derived cultured
DC and mediates their response to TGF-ß [16]. Here we
explored Runx3 function throughout DC lineage development
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using mice that lack Runx3 specifically in DC and their
progenitors. Runx3 ablation at defined developmental DC
stages led to largely impaired splenic CD4+/CD11b+ DC
compartment. Combined chromatin immunoprecipitation
sequencing (ChIP-seq) and gene expression analysis revealed
that Runx3 acts as a key gene expression regulator of CD11b
+Esamhi DC homeostasis. Accordingly, loss of Runx3 altered
gene expression profile of the residual Runx3 deleted (Runx3Δ)
Esamhi DC to a profile characteristic of WT Esamlow DC
subtype. Moreover, this transcriptional reprogramming yielded
functionally impaired Runx3Δ Esamhi DC compromising their
ability to prime CD4+ T cells. The results defined Runx3-
regulated target genes that participate in Runx3-mediated DC
lineage development and function.
Methods
Mice
The Runx3P1/P2-GFP KI and Runx3-/- (KO) mice were previously
described [17] [18] (Figure 1A). Mice lacking Runx3 in specific
DC progenitors were produced by crossing Runx3fl/fl mice [17]
onto Cebpα-Cre mice [19] or CD11c-Cre mice [20]. This mating
scheme generated Runx3fl/fl/Cebpα::Cre (Cebpα-DC-Runx3Δ)
or Runx3fl/fl/CD11c:Cre (CD11c-DC-Runx3Δ) mice, respectively.
C57BL/6 Ly5.2 mice were purchased from Harlan Laboratories
(Rehovot). C57BL/6 Ly5.1 mice and TCR-transgenic mice
harboring ovalbumin (OVA)-specific CD4+ or CD8+ T cells were
bred in the Weizmann animal facility. For generation of BM
chimeras C57BL/6 Ly5.1 mice were lethally irradiated (1050
Rad) and reconstituted by intravenous injection of 1:1 mixture
of C57BL/6 Ly5.1 and CD11c-DC-Runx3Δ BM cells. Mice were
analyzed 6-10 weeks later. This study was carried out in strict
accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health. The protocol was approved by the Committee on the
Ethics of Animal Experiments of the Weizmann Institute of
Science (Permit Number: 01190113-2). All surgery was
performed under sodium pentobarbital anesthesia, and all
efforts were made to minimize suffering.
Flow cytometric analysis
For analysis of BM DC precursors femurs and tibias BM cells
were suspended in ACK erythrocyte-lysis buffer (0.15M NH4Cl,
0.1M KHCO3, and 1mM EDTA in PBS), washed and then
stained with CD135 (A2F10), CD117 (2B8), CD115 (AFS98),
and lineage Ab cocktail: CD11b (M1/70), CD3 (145-2C11),
CD4 (GK1.5), CD8a (53-6.7), Gr1 (RB6-8C5), Sca-1 (D7),
B220 (RA3-6B2), Ter-119, CD11c (N418), and NK1.1 (PK136).
Splenic DC were obtained from spleens treated for 30 min with
collagenase D (1mg/ml C5138 Sigma) and DNase I (20ug/ml
Roche). DC were characterized using ACK-lyzed cell
suspensions as CD11chiMHCII+ CD4/CD8α or CD11b/Esam/
CD8α. pDC were characterized as CD11c/PDCA1/B220 and
monocytes as CD11b/CD115/Ly6c. DC subsets were analyzed
for maturation by staining with CD40 (3/23) and CD86 (GL-1).
Blood monocytes were detected as CD115/CD11b and Ly6C+
or Ly6C- cells. DC were analyzed for apoptosis by annexin V
and propidium iodide staining according to the manufacturer
instruction (eBiosciences). All Abs were purchased from
BioLegend or eBiosciences if not indicated otherwise.
FACSAria flow cytometer (BD Biosciences) was used for cell
sorting and forward scatter height versus forward scatter width
appearance was used to exclude dublets. Analysis using LSRII
flow cytometer (BD Biosciences) was conducted with
FACSDiva Version 6.2 software (BD Biosciences). FACS data
were further analyzed using FlowJo Version 9.3.2 software
(TreeStar).
RNA isolation and microarray gene expression analysis
Total RNA from sorted DC was extracted using the
miRNeasy Mini Kit (QIAGEN) including DNase digest
(QIAGEN). RNA purity was assessed with a BioAnalyzer 2100
(Agilent Technologies). Samples of 250ng RNA from each
isolated DC population was labeled and hybridized to
Affymetrix mouse exon ST 1.0 microarrays according to
manufacturer instructions. Microarrays were scanned using
GeneChip scanner 3000 7G. Each experiment was conducted
in duplicates or triplicates using RNA from independent FACS
isolated cells. Statistical analysis was performed using the
Partek® Genomics Suite (Partek Inc., St. Louis, Missouri
63141) software. CEL files (containing raw expression
measurements) were imported to Partek GS. The data was
preprocessed and normalized using the RMA (Robust Multichip
Average) algorithm [21] with GC correction. To identify
differentially expressed genes, One-Way ANOVA was applied.
Differential gene lists were created by filtering the genes based
on: absolute fold change >= 1.5, p <=0.05 and signal above
background in at least one microarray (log2 intensity >=6.5).
Log2 gene intensities were used for scatter plots (Partek) and
matrix plots containing: correlation, histogram and scatter plots
(using R language). Gene expression clusters for 224
transcripts were generated using log2 ratios with the Expander
SOM tool [22]. These transcripts were differentially expressed
in our and in [8] experiments and were above background in
both datasets. Microarray data is available at Gene Expression
Omnibus (GEO) under accession numbers GSE48589 (Runx3
function in CD4+ splenic DC) and GSE48590 (The affect of
specific ablation of Runx3 from Esam splenic DC).
ChIP-seq data acquisition and analysis
Two biological replicate ChIP-Seq experiments were
conducted for detection of Runx3-bound genomic regions using
in-house anti Runx3 Ab and 30x106 positive CD11c MACS
isolated (Miltenyi Biotec) DC. These cells were further purified
by FACS to CD11chiMHCII+CD4+ cDC subset. Isolated cells
were fixed in 1% formaldehyde and sonicated to yield DNA
fragments of ~300bp according to standard procedures
previously summarized in [23]. For immunoprecipitation, 40ul of
anti-Runx3 Ab were added to 15 mL of diluted, fragmented
chromatin; whole cell extract fragmented chromatin served as
control. DNA was purified using QIAquick spin columns
(QIAGEN). For ChIP-seq analysis, Illumina sequencing of short
reads (50 bp) was performed in one lane of Hiseq 2000 using
v2 clustering and sequencing reagents. For data analysis 70
million Runx3 IP and 74 million whole genome extract
sequences were aligned uniquely to the mouse genome (mm9)
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using bowtie [24]. Bound regions were detected using MACS2
[25]. Runx3 bound peaks and coverage data (bigWig files)
were uploaded to the UCSC genome browser [26]. GREAT
algorithm was applied to determine genes corresponding to
Runx3-bound peaks and ontology enrichment analysis [27].
Cistrome CEAS [28] was used to calculate average profile read
Figure 1.  Runx3 expression is restricted to splenic CD4+/CD11b+ DCs and to fraction of CMP and MDP.  (A) Schematic
representation of the Runx3 gene and the targeted alleles used to generate the Runx3-GFP reporter mice. P1 and P2 represents
promoter 1 and 2 respectively. (B) Flow cytometry analysis of WT or Runx3P1/P2-GFP BM cells gated for lineage negative cells and
stained for myeloid progenitor markers to identify GFP expression in CMP, MDP, CDP and preDC. WT littermate and Runx3P1/P2-
GFP mice are marked by red and blue lines, respectively. (C) Flow cytometry analysis of cells isolated from WT or Runx3P1/P2-
GFP mice. Dot plot of isolated splenic CD11c+MHCII+ DC stained for CD4+ and CD8+ DC subsets (upper panel). CD4+ and DN
DC express Runx3 (lower panel histograms). CD8+ DC are GFP negative indicating lack of Runx3 expression. All data in this figure
are representative of three independent experiments with one to two mice per group.
doi: 10.1371/journal.pone.0077490.g001
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near TSS and to generate venn diagrams. De-novo discovery
of TF binding sites was conducted using DREME [29]. Analysis
of co-bound zDC - Runx3 peaks was done using bedtools [30].
Statistical evaluation of fold enrichment distributions was done
using the R package. ChIP-seq data is available at Gene
Expression Omnibus (GEO) under accession number
GSE48588 (Genome-wide maps of Runx3 bound regions in
CD4+ splenic DC).
RT–qPCR and Western blotting
Total RNA was reverse-transcribed using miScript reverse
transcription kit (QIAGEN) according to manufacturer's
instructions. Quantitation of cDNAs was performed by qPCR
using Roche LC480 LightCycler with sequence-specific primers
and miScript SYBR Green PCR kit (QIAGEN). Target transcript
quantification was calculated relative to ACTB mRNA, which
served as an internal control. Standard errors were calculated
using REST [31]. For Western blot analysis FACS isolated DC
sub-populations were collected, washed once in PBS, proteins
extracted with RIPA buffer and analyzed by Western blotting
with anti Runx3 Ab [17]. GAPDH was used as an internal
loading control.
T-cell proliferation and Phagocytosis assays
CD4+ and CD8+ OVA-specific T cells were isolated from
spleens and lymph nodes of OT-II and OT-I TCR-transgenic
mice and CD4 or CD8 cells isolated by MACS (Miltenyi Biotec).
Cells were labeled with CFSE (Invitrogen) and coinjected into
the tail veins of recipient mice (2 X 106 cells/mouse). Twenty-
four hours later, 20ug of soluble OVA (Sigma-Aldrich) per
mouse was injected. Analysis of T-cell proliferation in spleens
of recipient mice was performed 96 hours following T-cell
transfer. For phagocytosis assay 200µl of 2.66% solid
Fluoresbrite Carboxylate were injected into the tail veins with
FITC labeled 0.5µm latex microspheres (Polysciences,
Warrington, PA). Analysis of splenic DC microspheres uptake
was performed 5 and 18 hours following injection.
Statistical analysis
Statistical significance was determined with unpaired, two
tailed Student’s t test. To identify differentially expressed
genes, One-Way ANOVA was applied. Spearman correlation
between microarray intensities was calculated using the R
package. zDC peaks were found to be overlapping Runx3
peaks more than expected by chance using the hyperbrowser
[32]. Specifically the test applied preserved the zDC regions
and the number of Runx3 peaks and randomized (Monto Carlo
test) the positions of Runx3 peaks with a constrain to the same
chromosome and to a similar distance from the TSS. Same p
value resulted in the opposite test (i.e. randomizing the zDC
peaks). Kolmogorov-Smirnov test was applied on the Runx3
peaks fold enrichment distributions using the R package
(ks.test) (http://www.R-project .org/).
Results
Expression of Runx3 during DC lineage development
To determine the developmental stages of the mononuclear
phagocyte lineage where Runx3 expression is acquired, we
took advantage of mice harboring a GFP reporter gene in their
Runx3 loci [17] (Figure 1A). Specifically, we analyzed BM
resident myeloid precursors (CMP, MDP, CDP and pre-DC), as
well as mature myeloid splenocytes, of compound transgenic
Runx3 P1/P2-GFP (Runx3P1-GFP/P2-GFP) mice that report activities
of the two known Runx3 promoters P1 and P2 [17]. Analysis of
BM-resident DC-progenitor populations revealed substantial
variation in the abundance of Runx3-expressing cells. Among
the common myeloid progenitor (CMP) cells (Lin-
CD135+CD117+CD115-) ~50% were positive for Runx3-P1 and
P2-GFP (Figure 1B and Figure S1A). The proportion of Runx3-
P1 and P2-GFP expressing cells declined in MDP (Lin-
CD135+CD117+CD115int) and CDP (Lin-
CD135+CD117lowCD115+) populations to ~30% and ~15%,
respectively (Figure 1B and Figure S1A). Runx3-P1 and P2-
GFP expression rose again to 25% in the pre-DC (Lin-
CD135+CD11c+MHC-II-) population (Figure 1B and Figure
S1A).
Reporter gene expression was absent from blood monocytes
and plasmacytoid DC (pDC) (Figure S1B). Among splenic
CD11chiMHCII+ cDC Runx3/GFP expression was readily
detected in CD4+CD8- DC and DN populations, but absent from
CD8+CD4- DC (Figure 1C). Further analysis indicated that
Runx3 expression was confined to CD11c+CD11b+ cDC (Figure
S1C) with Runx3/GFP highly expressed in both Esamhi and
Esamlow sub-populations (Figure S1D). Lewis et al. recently
proposed that Esamhi and Esamlow DC subsets might originate
along different pathways with only EsamhiCD11chiCD11b+ DC,
but not EsamlowCD11chiCD11b+ DC involving a CDP
intermediate [8].
Interestingly, a similar reporter gene expression pattern was
detected in cells derived from either Runx3P1-AFP/+ or Runx3P2-
EGFP/+ mice (Figure S1A and E), indicating that Runx3
expression in BM DC-progenitor subsets and mature CD11c
+CD11b+ DC was driven by both P1 and P2 promoters. In
summary, Runx3 expression was readily detected in sub-
populations of BM CMP, MDP and pre-DC as well as in splenic
CD11b+ DC, whereas Runx3 expression was absent from CD8+
DC, monocytes and pDC populations.
Runx3 regulates development of splenic CD11b+ DC
Because DC development is associated with alterations in
Runx3 expression levels (Figure S1A), we addressed its role in
DC lineage specification and homeostasis. Mice lacking Runx3
starting from the CMP or Pre-DC stage were generated by
crossing Runx3fl/fl mice [17] onto Cebpα-Cre mice [19] and
CD11c-Cre mice [20], respectively. To confirm efficient Runx3
ablation in these mouse models we performed a Western blot
analysis on FACS-isolated CD4+ DC of wild-type (WT) mice,
Runx3fl/fl Runx3fl/fl/Cebpα::Cre (Cebpα-DC-Runx3Δ) and
Runx3fl/fl/CD11c::Cre (CD11c-DC-Runx3Δ) mice (Figure S2A).
Corroborating the findings with Runx3P1/P2-GFP mice, Runx3
expression was confined to WT and Runx3fl/fl CD4+DC, but
Impaired Homeostasis of Runx3-/- CD11b+Esamhi DC
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absent from CD8+DC. In addition, CD4+DC isolated from
Cebpα-DC-Runx3Δ or CD11c-DC-Runx3Δ mice lacked Runx3
protein (Figure S2A).
FACS analysis of Cebpα-DC-Runx3Δ or CD11c-DC-Runx3Δ
splenocytes revealed a pronounced reduction in CD11chiMHCII
+ cells (Figure 2A). Detailed analysis of the splenic DC
compartment indicated that loss of Runx3 specifically affected
the CD11b+ subclass in both DC-Runx3Δ mouse strains (Figure
2B-D). No other hematopoietic cell populations besides
CD11chiMHCII+CD11b+ DC seemed to be compromised, as
evidenced by unaffected frequencies of B cells, T cells and
pDC in both DC-Runx3Δ mice compared to littermate controls
(Figure 2C and D). Of note, the reduction in splenic CD4+ and
DN DC affected both Esamhi and Esamlow DC in the Cebpα-DC-
Runx3Δ and CD11c-DC-Runx3Δ mouse strains (Figure 2E). The
reduction of Esamhi and Esamlow DC in these mice was
however not associated with increased apoptosis (Figure 2F).
FACS analysis of Runx3-/- mice [18] that lacked Runx3
throughout myelopoiesis recapitulated the DC phenotype
observed in the DC-Runx3Δ mouse strains (Figure S2B-D).
The finding that the two DC-lineage stage-specific Runx3Δ
mouse strains, as well as germ-line Runx3-mutants displayed a
similar impairment of their DC compartment suggested that
Runx3 may not be required at a specific lineage decision stage,
but rather be involved in DC homeostasis. To address this
issue we examined the ability of CD11c-DC-Runx3Δ BM cells to
replenish the DC compartment by conducting a competitive
BM-repopulation assay. A 1:1 mixture of CD11c-DC-Runx3Δ
BM cells (CD45.2) and WT BM cells (CD45.1) was transferred
into lethally irradiated recipient mice (CD45.1). Six to eight
weeks following the transfer spleens from experimental
(CD11c-DC-Runx3Δ/wt > wt) and control (Runx3+/+/wt > wt)
chimeras were analyzed for the distribution of CD4+/CD8+ and
DN DC. CD11c-DC-Runx3+/+ BM cells of the control group
efficiently repopulated the three DC subsets successfully
competing with the WT BM (Figure 2G left). In striking contrast,
CD11c-DC-Runx3Δ BM cells were severely impaired in
generating CD11chiMHCII+ cells (Figure 2G right). Specifically,
CD4+Runx3Δ DC and DN Runx3Δ DC were found outcompeted
by their WT counterparts, whereas Runx3Δ CD8+ were
overrepresented relative to WT CD8+ DC (Figure 2G right).
Collectively, these findings demonstrate a cell-autonomous
Runx3 function in CD4+ DC homeostasis with Runx3 loss
significantly reducing splenic CD4+ DC numbers (Figure 2).
Runx3 is required for lineage identity and homeostasis
of Esamhi DC
To elucidate the cell-intrinsic regulatory role of Runx3 during
splenic CD4+ DC homeostasis we sought to identify Runx3-
responsive genes driving this process. Comparison of Runx3-/-
and WT CD4+ DC expression profiles revealed 412
differentially expressed genes (Figure 3A and Table S1).
Significantly, several of these Runx3-responsive genes had
previously been implicated in DC lineage development and
homeostasis. For example, Irf8 [10] and Spic/PU.1 [33] were
upregulated while Irf4 [12] was downregulated in Runx3-
deficient CD4+ DC (Figure 3A and Figure S3A). Moreover,
comparative analysis of WT and Runx3Δ CD4+DC revealed
elevated levels of Esam and CD11b and reduced expression of
CD11c in CD11c+-Runx3Δ DC (Figure 3B and Figure S3B),
suggesting that loss of Runx3 particularly affected the Esamhi
DC population. This conclusion is supported by the earlier
findings that Runx3 is highly expressed in both CD11b+Esamhi
and CD11b+Esamlow DC (Figure S1C and D), but its loss
preferentially affected the CD11b+/Esamhi population (Figure 2).
Subsequently, we analyzed differential gene expression in
Runx3Δ and WT CD11b+Esamhi DC (Figure 3C). Interestingly,
66 (30%) of the 202 Runx3-responsive genes upregulated in
Runx3Δ CD11b+Esamhi DC were previously identified as
Esamlow DC specific [8] (Table S2). Consequently, the gene
expression signature of Runx3ΔCD11b+Esamhi DC
corresponded to that of WT Esamlow DC (Spearman correlation
values of 0.56 and 0.57 for Runx3ΔEsamhi/WTEsamlow) (Figure
3D), while its correlation value with WT CD11b+Esamhi
(Runx3ΔEsamhi/WT-Esamhi) was markedly diminished to 0.34
and 0.37 (Figure 3D). These findings indicated that loss of
Runx3 caused a shift of the CD11b+Esamhi population towards
a CD11b+Esamlow cell-identity manifested in altered gene
expression. This conclusion was supported by the observation
that the Runx3-/-CD4+ DC gene expression profile highly
correlated with CD11b+Esamlow DC (Figure S3C), but also with
that of RbpjΔCD11b+Esamlow DC [8]. These latter Esamlow DC
were derived from mice lacking the Notch2-pathway TF Rbpj
that regulates Esam expression [8]. Specifically, the correlation
values of Runx3-/-Esamhi to WT Esamlow DC and that of Runx3-/-
Esamhi to RbpjΔEsamlow DC were 0.72 and 0.70, respectively,
compared to a correlation value of 0.52 for Runx3-/-Esamhi to
WT Esamhi DC (Figure S3C).
We next integrated the Runx3 ChIP-seq data (see below)
with the differential gene expression results of Runx3ΔCD11b
+Esamhi DC and Runx3-/-CD4+ DC. Using this dataset we
performed clustering analysis using 224 Runx3-responsive
gene transcripts compared to WT CD11b+Esamlow and
RbpjΔCD11b+Esamlow DC datasets [8]. Six clusters were
identified (Figure 3E). Cluster 1-5 contained 186 Runx3-
responsive genes (either down or up -regulated), of which 127
(~70%) were bound by Runx3. Importantly, clusters 1-4
included 156 genes that were upregulated in both Runx3-
deficient CD11b+Esamhi DC and CD4+ DC experiments and
displayed a similar gene expression profile to that of WT
CD11b+Esamlow DC previously reported [8]. This observation
indicated that in WT CD11b+Esamhi DC Runx3 negatively
regulates these genes. We next used RT-qPCR analysis of
RNA from Runx3ΔCD11b+Esamhi, WT CD11b+Esamhi or WT
CD11b+Esamlow DC or FACS analysis to validate the clustering
microarray gene expression data. This analysis confirmed that
key WT CD11b+Esamlow DC-specific genes, including Clec12a,
Cx3cr1, Irf8 and Flt3 were markedly upregulated in
Runx3ΔCD11b+Esamhi DC (Figure 3F and G) along with genes
such as Kit and Itgax that were downregulated upon loss of
Runx3 (Figure 3B and G). Taken together the data support the
conclusion that Runx3 normally represses a number of critical
genes to facilitate the maintenance of Esamhi cell identity. Upon
loss of Runx3, Runx3ΔEsamhi DC acquired a gene expression
profile characteristic to Esamlow DC. Interestingly, this cell
identity shift of Esamhi to Esamlow DC did not affect their
Impaired Homeostasis of Runx3-/- CD11b+Esamhi DC
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Figure 2.  Runx3 is required for splenic CD11b+ DC lineage development.  (A) Representative profiles of splenocytes isolated
from Cebpα-DC-Runx3Δ (left) or CD11c-DC-Runx3Δ (right) mice stained for CD11c and MHCII. Comparisons between Cre- (upper)
and Cre+ (lower) littermates are shown. (B) Representative profiles of gated CD11chiMHCII+ splenic DC isolated from Cebpα-DC-
Runx3Δ (left) or CD11c-DC-Runx3Δ (right), stained for CD4 and CD8. Comparisons between Cre- (upper) and Cre+ (lower)
littermates are shown. Note the reduced proportion of CD4+ DC upon loss of Runx3. (C and D) Splenocytes were isolated from
Cebpα-DC-Runx3Δ (C), CD11c-DC-Runx3Δ (D) or littermate control WT mice (n=4, 6-8 week old). Cells were counted and total cell
numbers per mg tissue calculated and compared to that of littermate control. Each dot represents one independent animal. *P<0.05,
**P<0.01, ***P<0.001 (Students two-tailed t test). Shown are results of one experiment out of two with the same finding. (E)
Representative profiles of splenocytes isolated from Cebpα-DC-Runx3Δ (left) or CD11c-DC-Runx3Δ (right) mice gated for
CD11chiMHCII+ DC subset and analyzed for Esam and CD8. Comparisons between Cre- (upper) and Cre+ (lower) littermates are
shown. Shown representative of three independent experiments with one to two mice per group. (F) Lack of apoptosis among
Runx3-deficient cDC. Representative profiles of Runx3+/+ (left panel) and Runx3-/- (right panel) cDCs stained with Annexin-V and
with 7AAD viability dye. Shown representative of two independent experiments with one to two mice per group. (G) Graphic
summary of competitive BM-repopulation assay. Flow cytometric analysis of [Runx3+/+ (CD45.2) /WT (CD45.1) > WT (CD45.1)] (left)
and [CD11c-DC-Runx3Δ (CD45.2) /WT (CD45.1) > WT (CD45.1)] (right) chimeric mice 6-8 weeks after transplantation. CD45.2/
CD45.1 ratios were calculated for each cell population. Values <1 indicate out-competition of the mutant by WT (CD45.1) cells,
whereas values >1 show an advantage of Runx3Δ (CD45.2) cells. Representative results from one out of two independent
experiments are shown (mean ± SD) with 3 or more animals in each group. *P<0.05, **P<0.01, ***P<0.001 (Students two-tailed t
test).
doi: 10.1371/journal.pone.0077490.g002
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Figure 3.  Alteration in CD4+ and Esamhi DC gene expression due to loss of Runx3.  (A) Scatter plot of differentially expressed
genes in Runx3-deficient CD4+ DC and WT control DC. Splenic CD4+ DC from three Runx3Δ and WT mice were isolated by FACS,
RNA was isolated and subjected to microarray analysis. Shown are the mean intensities (log2) of WT and Runx3Δ CD4+ DC. Genes
that were up- or down- regulated due to Runx3Δ are marked by red or blue, respectively. Differential expression cut-off was set to
minimal absolute fold-change of 1.5, and p-value<=0.05. Selected relevant genes are indicated. (B) Expression of Esam (upper
panel) CD11b (middle panel) and CD11c (lower panel) in splenic DC subsets from Runx3+/+ (Runx3fl/fl) mice (red line) and CD11c-
DC-Runx3Δ mice (blue line). (C) Scatter plot of differentially expressed genes in CD4+Esamhi DC from WT and CD11c-DC-Runx3Δ
mice. Splenic Esamhi DC were obtained from two individual mice. Genes that were up- or down- regulated due to Runx3Δ are
marked by red or blue, respectively. Differential expression cut-off was set to minimal absolute fold-change of 1.5, and p-
value<=0.05. Selected relevant genes are indicated. (D) Gene expression log2 pairwise comparisons between WT-CD4+Esamhi,
CD11c-Runx3ΔCD4+Esamhi subsets and the published Esam experiment [8]. Compared are 162 genes differentially expressed in
the DC-Runx3ΔEsamhi experiment and in Lewis et al, 2011 Esam experiment [8]. The shown comparison of gene expression
intensities indicates Spearman correlation values numerically and by color (above main diagonal), histograms of expression values
(main diagonal) and scatter plots (below main diagonal). (E) Clusters showing Log2 ratio of gene expression of 224 genes (see
Methods) correlated with Runx3 occupied genomic regions. Runx3 binding (up to a distance of 200kb from TSS) is presented as
column No-1. Gene expression (Log2 ratio) was calculated for the following combination: column No-2 Runx3-/-CD4+ vs. WT-CD4+,
column No-3 DC-Runx3ΔEsamhi vs. CD4+, column No-4 WT Esamlow vs. Esamhi and column No-5 DC-RbpjΔ vs. Esamhi. Levels of up
or down regulation are color-coded. (F) RT-qPCR analysis of genes scored by differential gene expression of WT Esamhi and
Esamlow CD11b vs. Runx3Δ Esamhi populations. Data represents normalized expression values relative to WT Esamhi sample (±SD
of three assays from two biological repeats). (G) Histograms for Kit and Flt3 expression in Esamhi DC subset. Red and blue lines
represents WT CD11c (Runx3fl/fl) and CD11c-Runx3Δ mice, respectively.
doi: 10.1371/journal.pone.0077490.g003
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maturation state, as evidenced by the level of activation
markers (Figure S3D).
Identification of Runx3-regulated genes in splenic CD4+
DC
We next sought to identify among Runx3-responsive genes
those that were directly regulated by Runx3 and could
therefore contribute to the cell-phenotypic shift of Esamhi DC to
Esamlow DC. ChIP-seq was conducted using FACS-isolated
CD11chiMHCII+CD4+ splenic WT DC and anti-Runx3 antibodies
(Ab). Data analysis revealed that of the 15121 Runx3-bound
regions 9938 were associated with annotated genes (Figure
4A). Location analysis of these Runx3-occupied regions
relative to the nearest transcription start sites (TSS) of the
annotated genes, revealed that ~50% were placed ±10kb from
a gene TSS (Figure S4A and B). Runx3 ChIP-seq data
analysis using GREAT [27] indicated that Runx3-bound regions
were highly enriched for genes that belong to specific
functional categories, including antigen processing and
presentation (Figure S4C). To identify among the CD4+DC
Runx3-responsive genes those that were Runx3-regulated we
cross-analyzed Runx3 ChIP-Seq and differential gene
expression datasets. Of the 412 Runx3-responsive genes 316
were bound by Runx3 and defined as Runx3-regulated (Figure
4A). Forty percent (127) of these Runx3-regulated genes
belonged to the subset characteristic of WT CD11b+Esamlow
DC in Runx3-deficient CD4+ DC (Figure 3E), underscoring the
crucial role of Runx3 in specifying the Esamhi DC gene
expression signature. Among these Runx3-responsive genes,
Runx3 was found to occupy the genomic loci of Clec12a,
Cx3cr1, Flt3, Rbpj, Itgam and Itgax (Figure 4B).
Sequence analysis revealed that 86% of Runx3-occupied
genomic regions contained the canonic RUNX motif TGTGGT
(Figure 4C). Interestingly, Runx3-bound regions were also
enriched for the motif TGACGT comprising the binding site of
DC-specific TF zDC/zbtb46 [15] (Figure 4C). Moreover,
comparison of the published zDC ChIP-seq dataset [15] to
Runx3-occupied regions in splenic CD4+DC revealed that a
high proportion (66%) of zDC bound genes was co-bound by
Runx3 and that the zDC/Runx3 co-occupied regions were
significantly enriched in Runx3 binding (Figure S4D). This
observation is consistent with the possibility that Runx3 and
zDC cooperate in regulating DC specific gene expression
particularly as similar to Runx3, zDC participates in
homeostasis of splenic CD4+DC [13].
Runx3 is required for CD4+ DC-mediated T-cell priming
T cell priming and activation by DC link innate and adaptive
immunity and modulate tolerance vs. immune response. CD4+
T cells are preferentially primed by CD4+DC in a MHC-II
dependent manner [6,34]. CD4+ DC-dependent T cell priming
was reported to be impaired in DC-RbpjΔ mice that lack CD11b
+Esamhi DC [8], raising the possibility that also the Runx3Δ-
dependent phenotypic shift of CD4+Esamhi to CD4+Esamlow DC
would be associated with impaired T cell immunity. To address
this scenario, we isolated Ovalbumin (OVA)-specific CD8+ and
CD4+ T cells from TCR transgenic OT-I and OT-II mice, labeled
them with CFSE, to allow monitoring of in vivo proliferation and
transferred the cells into WT control and CD11c-DC-Runx3Δ
mice. Donor mice bore the congenic marker CD45.1, allowing
detection of grafted cells in the CD45.2+ recipient mice. Four
days following immunization with OVA the OT-I CD8+ T cell
graft underwent pronounced proliferation in both WT and
CD11c-DC-Runx3Δ recipients (Figure 5A upper panel). Thus,
the lack of Runx3 did not influence the cross-priming efficiency
of CD8+ DC. In contrast, the response of grafted OT-II CD4+ T
cells to the OVA challenge was impaired in CD11c-DC-Runx3Δ
mice as compared to control recipients (Figure 5A lower panel,
B and Figure S5A), attesting to the important role of Runx3 in
CD4+ DC ability to prime T cells. As EsamlowCD11b+ DC lack
MHC-II priming capacity [8] the diminished CD4+ T cell priming
in DC-Runx3Δ mice is most probably due to an intrinsic cell
defect in the EsamhiCD4+ DC. Consistent with this conclusion,
Runx3 bound (Figure 5C) and regulated expression (Figure
S4C) of classical MHC-II genes and its loss could therefore
affect MHC-II presentation. Together, the data indicate that
Runx3 not only participates in promotion and maintenance of
Esamhi DC identity, but also contributes to their CD4+ T cell
priming activity.
Reduced phagocytic capacity of Runx3-deficient
splenic CD11b+ DC
DC-mediated adaptive immune responses involve antigen
phagocytosis followed by MHC-dependent T cell priming. The
crucial contribution of Runx3 to the ability of EsamhiCD4+ DC to
prime CD4+ T cells posed the question as to whether it was
also required for phagocytic DC activity. To directly evaluate
this possibility we injected 1x1010 FITC-labeled latex beads to
WT and DC-Runx3Δ mice, and monitored uptake of fluorescent
beads by splenic DC, 5 and 18 hours later (Figure 5A and
Figure S5B). Of note, Runx3Δ CD4+/CD11b+ DC displayed a
reduced capacity to phagocytose the beads compared to WT
CD4+/CD11b+ DC, while Runx3Δ CD8+ DC exhibited phagocytic
capacity similar to WT DC (Figure 5D). Moreover, when we
divided the CD11b+ DC population and analyzed the
phagocytic ability of WT Esamhi and Esamlow DC independently,
we found that Esamhi DC exhibited a higher phagocytosis
potential than their Esamlow DC counterparts (Figure 5E and
Figure 5B). However, this higher phagocytic capacity of WT
Esamhi DC diminished upon Runx3 ablation (Figure 5E and
Figure S5C). Even more convincingly, injection of 1x1010 FITC-
labeled latex beads into chimeras of a 1:1 mixture of CD11c-
DC-Runx3Δ BM cells (CD45.2) and WT BM cells (CD45.1)
recapitulated the aberrant phagocytic phenotype of CD4+/
CD11b+ DC (Figure 5F). Collectively these results indicated
that in naive CD11b+/CD4+/Esamhi DC, Runx3 regulates basic
cDC functions including phagocytosis and antigen-processing.
Discussion
Extensive efforts have been made over the past decade to
elucidate the mechanisms underlying the production of DC-
progenitors and to delineate the heterogeneity and functions of
their downstream lineage cell subsets [7,35,36]. However,
information about the role of specific TF in DC development,
subset specification and homeostasis is still incomplete. Using
Impaired Homeostasis of Runx3-/- CD11b+Esamhi DC
PLOS ONE | www.plosone.org 8 October 2013 | Volume 8 | Issue 10 | e77490
Figure 4.  Analysis of Runx3 occupied genomic regions in splenic CD4+ DC.  (A) Venn diagram summarizing the overlap
between Runx3 ChIP-seq bound genes and differentially expressed genes in splenic CD4+ DC. (B) Runx3 binding-pattern on five
genomic loci differentially expressed in CD4+ DC. Shown are ChIP-seq Runx3 peaks and the normalized read coverage of whole
cell extract (top) and Runx3 ChIP (bottom) uploaded to UCSC Genome Browser mm9 genome assembly. The position of MACS2-
identifird Runx3 peaks is indicated by rectangles. For each panel the scale bar and diagram of gene exon structure are presented
on top or bottom, respectively. (C) Enriched RUNX and zDC TF motif among Runx3 bound regions. Motifs were identified de-novo
using the MEME-ChIP software.
doi: 10.1371/journal.pone.0077490.g004
Impaired Homeostasis of Runx3-/- CD11b+Esamhi DC
PLOS ONE | www.plosone.org 9 October 2013 | Volume 8 | Issue 10 | e77490
Figure 5.  Loss of Runx3 abrogates functional activities of CD4+ DC.  (A) CD4+ T cell priming in DC-Runx3Δ mice in vivo. CFSE-
labeled OVA-specific OT-I CD8+ T cells or OT-II CD4+ T cells were introduced to DC-Runx3Δ or WT control littermate mice followed
by immunization with OVA. Shown are flow cytometric analyses of transgenic T cell grafts recovered from immunized recipient mice.
Proliferation of OT-I CD8+ T cells (top) and OT-II CD4+ T cells (bottom) cells in DC-Runx3+/+ (red) or DC-Runx3Δ mice (blue)
compared to PBS immunized mice (green) and non-labeled cells (brown). Shown representative of two independent experiments
with two to three mice per group. (B) Total cell number of OT-II CD4+ T cell Proliferation quantification. PBS-immunized mice T cell
proliferation is set as one (n=5). ***P < 0.001 (Student’s two-tailed t test). (C) Runx3 binding-pattern on MHCII genomic loci. Shown
are ChIP-Seq tracing wiggle files uploaded to UCSC Genome Browser mm9 genome assembly and the normalized read coverage
of whole cell extract (top) and Runx3 ChIP (bottom). The position of MACS2-identified Runx3 peaks is indicated by rectangles. For
each panel the scale bar and diagram of gene exon structure are presented on top or bottom, respectively. (D and E) The capacity
of splenic DC subtypes to phagocytose latex beads was analyzed in DC-Runx3Δ (blue) and WT (red) littermate mice 18h after i.v.
injection of 1010 FITC-labeled 0.5μm latex beads. Shown are histograms of FITC-fluorescence in CD4+, CD8+ and DN DC subsets
(D) or in Esamhi and Esamlow DC subsets (E). Shown representative of two independent experiments with two mice per group with
the same finding. (F) The capacity of splenic DC to phagocytose latex beads was further analyzed using mixed BM chimera mice
18h after i.v. injection of 1010 FITC-labeled 0.5μm latex beads. Shown are histograms of FITC-fluorescence in CD4+ and
Esamhi DC subsets gated on WT CD45.1 (red) or DC-Runx3Δ CD45.2 (red). Shown representative of two independent experiments
with two mice per group.
doi: 10.1371/journal.pone.0077490.g005
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cell-specific targeting of Runx3 at various stages of DC lineage
development we show a cell-autonomous Runx3 requirement
for splenic CD11b+Esamhi DC homeostasis and function. In
contrast to its critical role in CD4+Esamhi DC specification and
homeostasis, Runx3 contributions to early DC developmental
stages are more modest. Accordingly, Runx3 expression levels
are quite low among the DC precursor populations.
Interestingly however, within the CMP, MDP and CDP
progenitors Runx3 expression marks a small but distinct cell
fraction comprising ~20-40% of the population. Whether the
fraction of Runx3-expressing CMP or MDP are already
committed to differentiate into the CD4+Esamhi DC subset or
rather have an equal potential to develop into CD8+ and CD11b
+ DC is an important issue to address in the future.
Nevertheless, this observation indicates that myeloid DC
precursor populations may not be homogenous [7]. In mature
splenic DC Runx3 expression is restricted to the CD11b+Esamhi
and CD11b+Esamlow subsets, whereas CD8+ DC are completely
devoid of Runx3 expression.
In good correlation with the expression pattern, inactivation
of Runx3 at distinct stages of DC lineage development led to
profound reduction of the CD4+Esamhi DC subset. Interestingly,
this Runx3-ablation-dependent reduction in CD4+Esamhi DC
was associated with extensive changes in CD4+Esamhi DC
gene expression, causing a shift in cell identity. Specifically, a
considerable number of Runx3-regulated genes that are
normally repressed in WT CD4+Esamhi DC became activated in
Runx3ΔCD4+Esamhi DC. Consequently, Runx3ΔCD4+Esamhi DC
acquired a gene expression signature resembling that of WT
Esamlow DC. Importantly, this gene expression shift of
Runx3ΔCD4+Esamhi led to acquisition of phenotypic features
characterizing the WT Esamlow DC subset [8], including a
compromised CD4+ T cell priming capacity, as well as
decreased phagocytosis.
The finding that in CD4+DC the zDC/Runx3 co-bound regions
comprised more than 50% of the genomic regions occupied by
this recently identified DC-specific TF [15] suggest that the two
TF cooperate in driving the CD4+Esamhi transcriptional program
and may collaborate in repressing Runx3-regulated Esamlow
DC genes. Of particular relevance to these recent findings is
the observation that inactivation of the E2-2 TF during pDC
maturation led to a major change in pDC gene expression
[37,38] so that E2-2-deficient pDC displayed induced or
repressed expression of genes characteristic to CD8+DC and
pDC respectively [37]. Both TGF-β and Notch signaling
pathways are important for DC development and function
[20,39]. These two pathways crosstalk through protein-protein
interaction of Notch intracellular domain with Smad3 [40].
Fainaru et al. have shown involvement of Runx3 in TGF-β
dependent DC function [16] and Runx3 participates in Notch-
mediated endothelial/mesenchymal transition [41]. Expression
of the Esam receptor by CD11b+ DC is regulated by the
Notch2-Rbpj signaling [8]. In this context, it is of note that
Runx3ΔCD4+Esamhi mice display elevated expression of Esam
indicating Runx3 involvement in DC Notch2 signaling pathway.
The idea that Runx3 participates in Notch2/TGF-β crosstalk
during DC development is further supported by data
documenting significant increased of Smad3 expression in
Runx3ΔCD4+ DC. In summary, Runx3 play a crucial role in
specifying Esamhi DC identity and function. Accordingly, loss of
Runx3 induces transcriptional reprogramming manifested in
phenotypic shift of Esamhi to Esamlow DC that compromises
CD4+ T cell priming activity.
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